John M. Thomason, DACVIM (SAIM): No relevant disclosure to display
Presentation Description / Summary: Anticoagulant and antiplatelet medications are commonly administered and are potentially life-saving preventative therapies in dogs and cats. However, it is difficult to predict if these medications are appropriately dosed. If there is inadequate or excessive inhibition of coagulation, patients could be at risk for the development of life-threatening thromboembolism or hemorrhage, respectively. Additionally, these medications are rarely administered as sole therapies, and other medications, such as proton-pump inhibitors to glucocorticoids, could adversely impact anticoagulation, once again, leading to inadequate or excessive coagulation. Based on our ongoing research, this session will review common anticoagulant and antiplatelet therapies, and discuss a practical approach to monitoring anticoagulant and antiplatelet therapy.
Learner Outcomes: Learn
Objectives: 1. Understand the common anticoagulant and antiplatelet therapies used in dogs and cats. 2. Understand potential drug interactions between thromboprophylaxic therapy and other commonly administered medications. 3. Understand the potential methods of monitoring the response to anticoagulant and antiplatelet therapy.
Learning Objectives:
Upon completion, participants will be able to understand the common anticoagulant and antiplatelet therapies used in dogs and cats.
Upon completion, participants will be able to understand potential drug interactions between thromboprophylaxic therapy and other commonly administered medications.
Upon completion, participants will be able to understand the potential methods of monitoring the response to anticoagulant and antiplatelet therapy.
